Methyl 2-[[4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl]methylcarbamoylamino]thiophene-3-carboxylate | 1026861-35-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Methyl 2-[[4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl]methylcarbamoylamino]thiophene-3-carboxylate
• CAS: 1026861-35-7
• 化学式: C₂₁H₂₀N₄O₅S
• 分子量: 440.48
• InChiKey: RIWGANPIOLHRMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  31
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  147
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• Methylene urea derivative as RAF kinasse inhibitors
  申请人：Merck Patent GmbH

  公开号：EP2426122A1

  公开（公告）日：2012-03-07

  The present invention relates to methylene urea derivatives of formula I, the use of the compounds of formula I as inhibitors of raf-kinase, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.

  本发明涉及式 I 的亚甲基脲衍生物、式 I 化合物作为雷夫激酶抑制剂的用途、式 I 化合物用于制造药物组合物的用途以及治疗方法，包括将所述药物组合物施用给患者。
• METHYLENE UREA DERIVATIVES
  申请人：Buchstaller Hans-Peter

  公开号：US20090298885A1

  公开（公告）日：2009-12-03

  The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
• Methylene Urea Derivatives
  申请人：Merck Patent GmbH

  公开号：US20130158076A1

  公开（公告）日：2013-06-20

  The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
• US8410143B2
  申请人：——

  公开号：US8410143B2

  公开（公告）日：2013-04-02